| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_10uM_T46 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_10uM_T58 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_10uM_T70 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_F_10uM_T49 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_F_10uM_T61 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_F_10uM_T73 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_Cl_10uM_T52 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_Cl_10uM_T64 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_Cl_10uM_T76 | Sample source:Breast cancer cells | Treatment:10 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_24h_RSL3_10uM_12 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_24h_RSL3_10uM_24 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_24h_RSL3_10uM_36 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_2h_RSL3_10uM_3 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_2h_RSL3_10uM_15 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_2h_RSL3_10uM_27 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_4h_RSL3_10uM_6 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_4h_RSL3_10uM_18 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_4h_RSL3_10uM_30 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_6h_RSL3_10uM_9 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_6h_RSL3_10uM_21 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_6h_RSL3_10uM_33 | Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_1uM_T44 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_1uM_T56 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_1uM_T68 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_F_1uM_T47 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_F_1uM_T59 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_F_1uM_T71 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_Cl_1uM_T50 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_Cl_1uM_T62 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_Cl_1uM_T74 | Sample source:Breast cancer cells | Treatment:1 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_RSL3_1uM_Ferrostatin1_3uM_T43 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 + 3 µM Ferrostatin | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_RSL3_1uM_Ferrostatin1_3uM_T55 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 + 3 µM Ferrostatin | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_RSL3_1uM_Ferrostatin1_3uM_T67 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 + 3 µM Ferrostatin | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_24h_RSL3_1uM_11 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_24h_RSL3_1uM_23 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_24h_RSL3_1uM_35 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_2h_RSL3_1uM_2 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_2h_RSL3_1uM_14 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_2h_RSL3_1uM_26 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_RSL3_1uM_T42 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_RSL3_1uM_T54 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_RSL3_1uM_T66 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_4h_RSL3_1uM_5 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_4h_RSL3_1uM_17 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_4h_RSL3_1uM_29 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_6h_RSL3_1uM_8 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_6h_RSL3_1uM_20 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_6h_RSL3_1uM_32 | Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_3uM_T45 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_3uM_T57 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_3uM_T69 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 1 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_F_3uM_T48 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_F_3uM_T60 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_F_3uM_T72 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 2 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_Ti41_Cl_3uM_T51 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_Ti41_Cl_3uM_T63 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_Ti41_Cl_3uM_T75 | Sample source:Breast cancer cells | Treatment:3 µM Comp. 3 | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_24h_DMSO_10 | Sample source:Breast cancer cells | Treatment:DMSO | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_24h_DMSO_22 | Sample source:Breast cancer cells | Treatment:DMSO | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_24h_DMSO_34 | Sample source:Breast cancer cells | Treatment:DMSO | time point:24 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_2h_DMSO_1 | Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_2h_DMSO_13 | Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_2h_DMSO_25 | Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n1_DMSO_T41 | Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n2_DMSO_T53 | Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210324_Rescue_Gust_compounds_2h_n3_DMSO_T65 | Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_4h_DMSO_4 | Sample source:Breast cancer cells | Treatment:DMSO | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_4h_DMSO_16 | Sample source:Breast cancer cells | Treatment:DMSO | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_4h_DMSO_28 | Sample source:Breast cancer cells | Treatment:DMSO | time point:4 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n1_6h_DMSO_7 | Sample source:Breast cancer cells | Treatment:DMSO | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n2_6h_DMSO_19 | Sample source:Breast cancer cells | Treatment:DMSO | time point:6 h | absolute intensities |
| Reversed phase NEGATIVE ION MODE | 210309_MDA_Timecourse_RSL3_n3_6h_DMSO_31 | Sample source:Breast cancer cells | Treatment:DMSO | time point:6 h | absolute intensities |
Return to study ST003261 main page
Download data matrix(Exploration of RSL3 or Chlorido[N,N’-disalicylidene-1,2-phenylenediamine]iron(III) complex-induced changes in the phospholipid oxidation of MDA-MB-231 breast cancer cells Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|